COVID-19 J&J COVID-19 Vaccine: 99% of Participants Developed Neutralizing Antibodies September 29, 2020
COVID-19 September 16, 2020 Celltrion Revealed Results from Phase 1 Trial of COVID-19 Monoclonal Antibody TherapyCelltrion announced positive preliminary results from Phase 1 clinical trial.
